The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: JPMorgan upgraded Netflix (NFLX) to Overweight from Neutral with a price target of $120, down from $124, after reinstating coverage following a period of restriction. The firm believes Netflix is a "healthy organic growth story," driven by strong content, global subscriber growth, continued pricing power, and an "under-monetized" advertising tier. Piper Sandler upgraded CrowdStrike (CRWD) to Overweight from Neutral with an unchanged price target of $520. The firm notes the stock is down 21% year-to-date on AI concerns that have "subsumed the narrative in security," and says it views the selloff as "well overdone." Piper Sandler upgraded Restaurant Brands(QSR) to Overweight from Neutral with a price target of $84, up from $71, following the company's Investor Day. At the event, the team put together a compelling presentation and discussion, the net of which has the firm feeling like the stock is ready to enter a period of outperformance. Stifel also upgraded Restaurant Brands to Buy from Hold. TD Cowen upgraded Twilio (TWLO) to Buy from Hold with a price target of $160, up from $125. The firm sees AI agents becoming a bigger part of everyday life and says Twilio is a "key enabler" of AI-driven business-to-consumer engagements. Argus upgraded Pfizer (PFE) to Buy from Hold with a $35 price target. The firm is positive on the company's recent additions to its GLP-1 pipeline along with its "robust" programs in oncology and hematology, saying it has greater confidence in Pfizer's ability to grow the top and bottom lines in post-2028 period. Top 5 Downgrades: Argus downgraded Pinterest (PIN) to Hold from Buy. The firm is citing the company facing obstacles to growth as retailers spend less on advertising due to tariffs while larger competitors like Alphabet (GOOGL) are able to spend more on AI tools. TD Cowen downgraded GitLab (GTLB) to Hold from Buy with a price target of $29, down from $56. The firm has concerns about GitLab's competitive risks from Anthropic Claude Code and OpenAI Codex. Craig-Hallum downgraded Thermon Group (THR) to Hold from Buy with a $51 price target following announced combination with Ceco Environmental (CECO) for $2.2B or 17-times EBITDA. Wedbush downgraded Playtika (PLTK) to Neutral from Outperform with a price target of $3, down from $7, as SuperPlay earnouts constrain free cash flow. With $734M in total remaining earnout payments locked in on the balance sheet, Wedbush believes Playtika is unable to organically deleverage ahead of its 2027 and 2028 refinancing windows without severely limiting its ability to return capital to shareholders. Wells Fargo downgraded AZZ Inc.(AZZ) to Equal Weight from Overweight with a price target of $132, up from $127. The firm says its downgrade reflects strong recent share price performance despite lackluster 2027 guidance, more muted margin growth implied, and increasing paint competition from North America steel mills. Story Continues Top 5 Initiations: Barclays reinstated coverage of Netflix (NFLX) with an Equal Weight rating and $115 price target. The stock's valuation in the near term should be supported by potential estimates upside as the company walks away from Warner Bros. (WBD) assets, but is likely to "embed concerns" around the reasons for bidding on the assets, says the firm. Craig-Hallum initiated coverage of Beachbody Company(BODI) with a Buy rating and $15 price target. The firm believes the company has demonstrated tremendous execution on the cost phase of the turnaround and now has several "irons in the fire" to drive growth, including the launch of Shakeology, P90X and Insanity products to retail for the first time, the first new P90X program in 20 years and "10-Minute BODi," a fitness program aimed at the 180M Americans who are inactive. Goldman Sachs initiated coverage of Forgent Power Solutions(FPS) with a Buy rating and $48 price target. Goldman says Forgent is one of the few companies that can deliver the entire powertrain to a data center and will benefit from being the marginal supplier of capacity. KeyBanc, JPMorgan, TD Cowen, Oppenheimer, Wolfe Research, and Jefferies also started the stock with Buy-equivalent ratings, while Morgan Stanley and Baird initiated coverage of the name with Neutral-equivalent ratings. KeyBanc initiated coverage of Bob's Discount Furniture(BOBS) with an Overweight rating and $28 price target, which represents 32% upside. The firm views the company as a "compelling: small-cap growth story. JPMorgan, BofA, UBS, RBC Capital, and Morgan Stanley also started the stock with Buy-equivalent ratings, while Goldman Sachs and Baird initiated coverage of the name with Neutral-equivalent ratings. Wells Fargo initiated coverage of Genmab (GMAB) with an Overweight rating and $40 price target. The firm believes the company's upcoming Epkinly and petosemtamab readouts are "largely de-risked" based on the Phase 2 data. View Comments
Netflix upgraded, Pinterest downgraded: Wall Street's top analyst calls
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...